Using mass spectrometry to validate mouse models of tauopathy

Using mass spectrometry to validate mouse models of tauopathy

Bibliographic Details
Main Authors:	Yan Yan, Casey N. Cook
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Series:	Molecular Neurodegeneration
Subjects:	Tau Alzheimer’s disease Frontotemporal dementia Phosphorylation Mouse model Tauopathy
Online Access:	https://doi.org/10.1186/s13024-023-00615-6

Similar Items

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
by: Caterina Giacomini, et al.
Published: (2018-05-01)

Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology
by: David J. Koss, et al.
Published: (2016-07-01)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
by: Priyanka Rawat, et al.
Published: (2022-10-01)

“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies
by: Yuxing Xia, et al.
Published: (2021-06-01)

Zebrafish Models to Study New Pathways in Tauopathies
by: Clément Barbereau, et al.
Published: (2021-04-01)

Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation
by: Yuxing Xia, et al.
Published: (2023-05-01)

Common mouse models of tauopathy reflect early but not late human disease
by: Kathrin Wenger, et al.
Published: (2023-02-01)

Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
by: Taeko Kimura, et al.
Published: (2018-02-01)

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
by: Naruhiko Sahara, et al.
Published: (2023-04-01)

<i>Caenorhabditis elegans</i> Models to Investigate the Mechanisms Underlying Tau Toxicity in Tauopathies
by: Carmina Natale, et al.
Published: (2020-11-01)

Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
by: M. Catarina Silva, et al.
Published: (2020-11-01)

Novel aspects of the phosphorylation and structure of pathological tau: implications for tauopathy biomarkers
by: Taeko Kimura, et al.
Published: (2024-02-01)

Tau interactome and RNA binding proteins in neurodegenerative diseases
by: Tomas Kavanagh, et al.
Published: (2022-10-01)

Early impairments of visually-driven neuronal ensemble dynamics in the rTg4510 tauopathy mouse model
by: Aleksandra Parka, et al.
Published: (2023-03-01)

Constant Levels of Tau Phosphorylation in the Brain of htau Mice
by: Joerg Neddens, et al.
Published: (2020-08-01)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
by: L. Arouche-Delaperche, et al.
Published: (2023-01-01)

Heparan Sulfate Proteoglycans in Tauopathy
by: Yanan Zhu, et al.
Published: (2022-11-01)

Glial contributions to neurodegeneration in tauopathies
by: Cheryl E. G. Leyns, et al.
Published: (2017-06-01)

Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation
by: Matthew R. Barron, et al.
Published: (2020-03-01)

Frontotemporal Dementia P301L Mutation Potentiates but Is Not Sufficient to Cause the Formation of Cytotoxic Fibrils of Tau
by: Kuang-Wei Wang, et al.
Published: (2023-10-01)

Targeting tauopathy with engineered tau-degrading intrabodies
by: Gilbert Gallardo, et al.
Published: (2019-10-01)

Novel autoimmune response in a tauopathy mouse model
by: Carlos J Nogueras-Ortiz, et al.
Published: (2014-01-01)

Astrocytes in Tauopathies
by: Matthew J. Reid, et al.
Published: (2020-09-01)

Evaluating the efficacy of purchased antisense oligonucleotides to reduce mouse and human tau in vivo
by: Pranav Vemula, et al.
Published: (2023-12-01)

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
by: Jakub Sinsky, et al.
Published: (2021-08-01)

Expanding the phenotypic associations of globular glial tau subtypes
by: James R. Burrell, et al.
Published: (2016-01-01)

Structural MRI Reveals Cervical Spinal Cord Atrophy in the P301L Mouse Model of Tauopathy: Gender and Transgene-Dosing Effects
by: Thomas Sartoretti, et al.
Published: (2022-05-01)

Magnetic Resonance Imaging in Tauopathy Animal Models
by: Ruiqing Ni, et al.
Published: (2022-01-01)

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
by: Yijun Chen, et al.
Published: (2023-07-01)

Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice
by: Taiki Kambe, et al.
Published: (2011-06-01)

Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
by: Yan Lin, et al.
Published: (2020-01-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Increased neuronal activity in motor cortex reveals prominent calcium dyshomeostasis in tauopathy mice
by: Qian Wu, et al.
Published: (2021-01-01)

Response: Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
by: Yan Lin, et al.
Published: (2020-07-01)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
by: Garrett S. Gibbons, et al.
Published: (2019-03-01)

Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-12-01)

DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
by: Geraldine Zimmer-Bensch, et al.
Published: (2021-11-01)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
by: Shengnan Zhang, et al.
Published: (2022-09-01)

Tau; One Protein, So Many Diseases
by: Parisa Tabeshmehr, et al.
Published: (2023-02-01)

Sex-Related Motor Deficits in the Tau-P301L Mouse Model
by: Luana Cristina Camargo, et al.
Published: (2021-09-01)